News and Annoucements
Here we will post News and Announcements concerning the HPCC and its associated partners.
If you are interested in getting News shared within the HPCC, please feel free to contact us .
Meetings
An intensive interdisciplinary exchange within the HPCC is mandatory for initiation and elaboration of research projects. Therefore, the partners meet and discuss current ongoing research projects within regular monthly virtual and face-to-face meetings. While some of the meetings are solely for internal stakeholders, others may be open for the interested scientific community, as well as non-scientific audiences.
If you wish to propose a topic of a talk or attend a specific meeting, you may contact us .
See below a list of upcoming and past meetings:
| Date | Presenter / Institution | Topic |
|---|---|---|
| 25.11.2024, 17h s.t. | Fabian Falkenbach, Martini-Klinik am UKE | Update PSMA-RGS |
| 28.10.2024, 17h s.t. | Anne Fassl, Goethe University Frankfurt, Frankfurt Cancer Institute, University Hospital Frankfurt | Challenges and opportunities for targeted therapeutics in prostate cancer - identifying targets and developing models for pre-clinical therapeutic development |
| 30.09.2024, 17-19h s.t. | HPCC-Minisymposium | Programm |
| 24.06.2024, 17h s.t. | Tobias Maurer, Martini-Klinik am UKE | Erste Ergebnisse der BioPoP-Studie (Identifizierung prädiktiver Biomarker für erfolgreiche Salvagechirurgie beim PSMA-PET-positiven oligometastatischen Prostatakarzinomrezidiv); NCT 04324983 |
| 27.05.2024, 17h s.t. | Francesca Demichelis, Vice-Rector for Research Computational and Functional Oncology Laboratory Department of Cellular, Computational and Integrative Biology (CIBIO) University of Trento (IT) | The PRIME program, multi-modal clinical testing of prostate cancer patient plasma |
| 29.04.2024, 17h s.t. | Su Jung Oh-Hohenhorst, Martini-Klinik am UKE | Anticancer effect of statins in advanced therapy-resistant prostate cancer cells |
| 25.03.2024, 17h s.t. | Daniel Köhler, Klinik für Diagnostische und Interventionelle Radiologie | Pelvic Rosetta Classification (PRC) Project |
| 29.01.2024, 17h s.t. | Tobias Maurer, Martini-Klinik am UKE | PSMA-radioguided Surgery: Update |
| 27.11.2023, 17h s.t. | Stefan Werner, Zentrum für Experimentelle Medizin, Institut für Tumorbiologie | Update on Liquid Biopsy approaches in prostate cancer |
| 30.10.2023, 17h s.t. | Alexander Schlaefer, Institut für Medizintechnische und Intelligente Systeme / TUHH | Robotik & KI: aktuelle Arbeiten und Projekte mit Bezug zur Prostata |
| 25.09.2023, 17h s.t. | Wael Mansour Department of Radiotherapy and Radiooncology, University Medical Center Hamburg-Eppendorf | Targeting the ERG Fusion-Positive Prostate Cancer: Towards personalization cancer therapy |
| 25.08.2023, 17h s.t. | Nadja Strewinski II. Medizinische Klinik / UKE ; Experimentelle Onkologie, Universitäres Cancer Center Hamburg (UCCH) - Hubertus Wald Tumor Center Sergey Dyshlovoy II. Medizinische Klinik / UKE ; Experimentelle Onkologie, Universitäres Cancer Center Hamburg (UCCH) - Hubertus Wald Tumor Center | Carboplatin und Cabatzitaxel beim AVPC: präklinische und klinische Daten Transdiffenzierung unter Langzeit- Taxanexposition |
| 26.06.2023, 17h s.t. | Nynke van den Berg, Clinical Project Manager Fluorescence Imaging; Intuitive Surgical, Sunnyvale, California, USA | PSMA-targeted fluorescence guidance for robotic-assisted prostatectomy |
| 22.05.2023, 17h s.t. | Su Jung Oh-Hohenhorst, Martini-Klinik am UKE, Centre de recherche du CHUM/Montréal | Update on projects pursued at Centre de recherche du CHUM/Montréal |
| 27.03.2023, 17h s.t. | Robin Khatri, Institut für medizinische Systembiologie / bAIome Center for Biomedical AI, Center for Molecular Neurobiology / UKE | Unleashing the Power of Language: Applications of Large Language Models in Life and Medical Sciences |
| 27.02.2023, 17h s.t. | Lina Merkens, Zentrum für Experimentelle Medizin, Institut für Tumorbiologie | Liquid biopsy approaches to determine tumor cell heterogeneity in advanced prostate cancer |
| 30.01.2023, 17h s.t. | Daniel Köhler, Klinik für Diagnostische und Interventionelle Radiologie | Intraoperative Präparate-PET/CT bei primärer radikalen Prostatektomie |
| 28.11.2022, 17h s.t. | Stefan Werner, Zentrum für Experimentelle Medizin, Institut für Tumorbiologie | CtBP polymerization: A novel molecular principle in androgen receptor signaling |
| 24.10.2022, 17h s.t. | Mohamed Elsesy, Department of Radiotherapy and Radiooncology, University Medical Center Hamburg-Eppendorf | Patient-derived organoids as pre-clinical models for personalized therapy in prostate cancer |
| 26.09.2022, 17h s.t. | Malte Holzapfel, Fraunhofer-Zentrum für Angewandte Nanotechnologie CAN / Hamburg | Strukturoptimierung Macrocyclischer Chelatoren für Metallbasierte Diagnostik und Therapie |
| 27.06.2022, 17h s.t. | Sergey A. Dyshlovoy, II. Medizinische Klinik / UKE ; Experimentelle Onkologie, Universitäres Cancer Center Hamburg (UCCH) - Hubertus Wald Tumor Center | Salvage chemotherapy with cisplatin, ifosfamide, and paclitaxel in metastatic castration-resistant prostate cancer |
| 30.05.2022, 17h s.t. | Moritz Kaune und Nadja Strewinsky, II. Medizinische Klinik / UKE | In vitro and In vivo investigations of the anticancer activity of a derivative of the marine alkaloid Ascididemine in androgen- independent and neuroendocrine prostate cancer |
| 28.03.2022, 17h s.t. | Alexander Schlaefer, Institut für Medizintechnische und Intelligente Systeme / TUHH | Robotics and AI related to prostate cancer: an update on work at MTEC |
| 28.02.2022, 17h s.t. | Stefan Bonn, Institut für medizinische Systembiologie / bAIome Center for Biomedical AI, Center for Molecular Neurobiology / UKE | AI-based prediction of prostate cancer outcome using pathology images and/or patient data |
| 31.01.2022, 17h s.t. | Su Jung Oh-Hohenhorst, Martini-Klinik am UKE, Centre de recherche du CHUM/Montréal | Use of microfluidics for 3D-culturing of patient-derived prostate cancer and preclinical screening of personalized treatment strategies |
| 29.11.2021, 17h s.t. | Thorsten Frenzel, Klinik für Strahlentherapie / UKE | Lokal ablative Strahlenbehandlung im Xenograft Prostata-Maus-Tumormodell |
| 25.10.2021, 17h s.t. | Britta Fritzsche, Zentrum für Onkologie, Universitäres Cancer Center Hamburg (UCCH), UKE | Vorstellung der UCCH-Biobank-Infrastruktur |